Komori
Japan Tissue Engineering (7774) · PolicyRestated

Policy on Large-Scale Purchases Emphasizing Corporate Value and the Common Interests of Shareholders

First written in FY2019. 2 of 4 entries say "Restated". Latest entry: FY2024.

4entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2019 – FY2020AdvancedFY2021-Q32019: 120192020: 120202021: 120212022: 020222023: 020232024: 12024
Same theme, other companies
Policy of Respecting Shareholder Will Regarding Company ControlA theme 54 companies write about · 3 as a headwind · 26 as a tailwind

The whole theme swung hardest in 2024: 2 of 18 companies on the "Worse" side.

46 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 54 companies compared. The sentences above are computed from all 54.
Full recordFilings, disclosures and news, newest first
  1. FY2024RestatedAnnual report

    「Ultimately, we believe that the decision on whether to accept a large-scale share purchase proposal should be left to the Company's shareholders.」

    The Company continues to follow its basic policy of not uniformly rejecting large-scale purchases, while prioritizing the securing of the necessary information and time and shareholder judgment.
  2. FY2021-Q3AdvancedAnnual report

    「At a meeting of the Board of Directors held on 29 January 2021, the Company resolved to express its opinion in favor of the tender offer for the Company's common shares (the "Company Shares") by TEIJIN LIMITED (the "Tender Offeror"), to leave the decision on whether to tender the Company Shares to the Company's shareholders, and to enter into a capital and business alliance agreement with the Tender Offeror (the "Capital and Business Alliance Agreement"). The agreement was executed on the same date.」

    In accordance with its policy for responding to large-scale purchases, the Company expressed its opinion in favor of TEIJIN LIMITED's tender offer, left the decision on whether to tender the shares to shareholders, and entered into a capital and business alliance agreement on the same date.
  3. FY2020RestatedAnnual report

    「Ultimately, we believe that the decision on whether to accept a large-scale share purchase proposal should be left to the Company's shareholders.」

    The Company continues to follow its basic policy of not uniformly rejecting large-scale purchases, while prioritizing the securing of the necessary information and time and shareholder judgment.
  4. FY2019First statedAnnual report

    「As a company whose shares are listed on a financial instruments exchange, we respect the free trading of our shares in the market and do not categorically oppose a large-scale purchase of our shares by a particular party, provided that it contributes to securing and enhancing our corporate value and, consequently, the common interests of shareholders. We also believe that the ultimate decision on whether to accept a proposal for a large-scale purchase of shares should be left to our shareholders.」

    The company has, for the first time as a separate theme, presented a basic policy of not categorically opposing large-scale purchases, while giving priority to shareholder judgment, securing the time and information necessary for consideration, and negotiating with the purchaser.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Japan Tissue Engineering's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.